PL2657227T3 - Nowa podstawiona pochodna izochinoliny - Google Patents
Nowa podstawiona pochodna izochinolinyInfo
- Publication number
- PL2657227T3 PL2657227T3 PL11851146.8T PL11851146T PL2657227T3 PL 2657227 T3 PL2657227 T3 PL 2657227T3 PL 11851146 T PL11851146 T PL 11851146T PL 2657227 T3 PL2657227 T3 PL 2657227T3
- Authority
- PL
- Poland
- Prior art keywords
- novel substituted
- isoquinoline derivative
- substituted isoquinoline
- derivative
- novel
- Prior art date
Links
- 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010286445 | 2010-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2657227T3 true PL2657227T3 (pl) | 2016-09-30 |
Family
ID=46313995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11851146.8T PL2657227T3 (pl) | 2010-12-22 | 2011-12-21 | Nowa podstawiona pochodna izochinoliny |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8883792B2 (pl) |
| EP (1) | EP2657227B1 (pl) |
| JP (1) | JP5781093B2 (pl) |
| KR (1) | KR101911324B1 (pl) |
| CN (1) | CN103270024B (pl) |
| AU (1) | AU2011345969B2 (pl) |
| BR (1) | BR112013015604B1 (pl) |
| CA (1) | CA2822787C (pl) |
| CY (1) | CY1117560T1 (pl) |
| DK (1) | DK2657227T3 (pl) |
| EA (1) | EA022646B1 (pl) |
| ES (1) | ES2571529T3 (pl) |
| HR (1) | HRP20160465T1 (pl) |
| HU (1) | HUE029976T2 (pl) |
| MX (1) | MX2013007296A (pl) |
| NZ (1) | NZ612336A (pl) |
| PL (1) | PL2657227T3 (pl) |
| PT (1) | PT2657227T (pl) |
| TW (1) | TWI527799B (pl) |
| WO (1) | WO2012086727A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021042126A (ja) * | 2017-12-27 | 2021-03-18 | 佐藤製薬株式会社 | アリールオキシ化合物 |
| BR112021011739A2 (pt) * | 2018-12-17 | 2021-08-31 | D. Western Therapeutics Institute, Inc. | Nova forma de isoquinolina sulfonamida |
| WO2020129877A1 (ja) | 2018-12-18 | 2020-06-25 | 株式会社デ・ウエスタン・セラピテクス研究所 | イソキノリンスルホニルクロリド酸付加塩及びその製造方法 |
| US20220119350A1 (en) | 2019-02-22 | 2022-04-21 | Glaukos Corporation | Compounds for the treatment of ocular disease |
| BR112021018481A2 (pt) | 2019-03-27 | 2021-11-23 | Curasen Therapeutics Inc | Agonista adrenérgico beta e métodos para usar o mesmo |
| TW202525783A (zh) * | 2019-07-01 | 2025-07-01 | 美商古拉森療法公司 | β腎上腺素激動劑及其使用方法 |
| CN110616439B (zh) * | 2019-10-31 | 2020-06-30 | 安阳师范学院 | 电化学氧化合成4-磺酸取代异喹啉酮衍生物的方法 |
| AU2021331624A1 (en) * | 2020-08-31 | 2023-05-04 | Visus Therapeutics, Inc. | Compounds and formulations for treating ophthalmic diseases |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6169085B1 (en) | 1995-03-10 | 2001-01-02 | G. D. Searle & Company | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| US6667307B2 (en) | 1997-12-19 | 2003-12-23 | G.D. Searle & Co. | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| US5985870A (en) | 1995-03-10 | 1999-11-16 | G.D. Searle & Co. | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| US5705500A (en) * | 1995-03-10 | 1998-01-06 | G.D. Searle & Co. | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| DE69634414T2 (de) * | 1995-12-21 | 2005-11-17 | Alcon Laboratories, Inc., Fort Worth | Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie |
| JP2005232175A (ja) * | 2004-01-21 | 2005-09-02 | Asahi Kasei Pharma Kk | 5−置換イソキノリン医薬 |
| US20090275099A1 (en) | 2004-04-27 | 2009-11-05 | Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| US20050272723A1 (en) | 2004-04-27 | 2005-12-08 | The Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| WO2006036664A1 (en) * | 2004-09-23 | 2006-04-06 | Amgen Inc. | Substituted sulfonamidopropionamides and methods of use |
| US7517991B2 (en) | 2004-10-12 | 2009-04-14 | Bristol-Myers Squibb Company | N-sulfonylpiperidine cannabinoid receptor 1 antagonists |
| US8455514B2 (en) * | 2008-01-17 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-and 7-amino isoquinoline compounds and methods for making and using the same |
| CA2719907A1 (en) | 2008-04-04 | 2009-10-08 | Merck Sharp & Dohme Corp. | Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| SI2315740T1 (en) | 2008-07-08 | 2018-03-30 | Catabasis Pharmaceuticals, Inc. | Fatty acids acetylated salicylates and their uses |
| EP3828172A1 (en) | 2009-05-01 | 2021-06-02 | Aerie Pharmaceuticals, Inc. | Dual mechanism inhibitors for the treatment of disease |
| US8951997B2 (en) | 2009-06-19 | 2015-02-10 | D. Western Therapeutics Institute, Inc. | Substituted isoquinoline derivative |
-
2011
- 2011-12-21 PT PT118511468T patent/PT2657227T/pt unknown
- 2011-12-21 NZ NZ612336A patent/NZ612336A/en unknown
- 2011-12-21 AU AU2011345969A patent/AU2011345969B2/en active Active
- 2011-12-21 KR KR1020137015956A patent/KR101911324B1/ko active Active
- 2011-12-21 BR BR112013015604-0A patent/BR112013015604B1/pt active IP Right Grant
- 2011-12-21 MX MX2013007296A patent/MX2013007296A/es active IP Right Grant
- 2011-12-21 EA EA201390939A patent/EA022646B1/ru unknown
- 2011-12-21 JP JP2012549860A patent/JP5781093B2/ja active Active
- 2011-12-21 HR HRP20160465TT patent/HRP20160465T1/hr unknown
- 2011-12-21 PL PL11851146.8T patent/PL2657227T3/pl unknown
- 2011-12-21 DK DK11851146.8T patent/DK2657227T3/en active
- 2011-12-21 CN CN201180061578.2A patent/CN103270024B/zh active Active
- 2011-12-21 CA CA2822787A patent/CA2822787C/en active Active
- 2011-12-21 WO PCT/JP2011/079725 patent/WO2012086727A1/ja not_active Ceased
- 2011-12-21 HU HUE11851146A patent/HUE029976T2/en unknown
- 2011-12-21 EP EP11851146.8A patent/EP2657227B1/en active Active
- 2011-12-21 ES ES11851146T patent/ES2571529T3/es active Active
- 2011-12-21 US US13/995,300 patent/US8883792B2/en active Active
- 2011-12-22 TW TW100148109A patent/TWI527799B/zh active
-
2016
- 2016-05-27 CY CY20161100465T patent/CY1117560T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2013007296A (es) | 2013-08-26 |
| CY1117560T1 (el) | 2017-04-26 |
| ES2571529T3 (es) | 2016-05-25 |
| WO2012086727A1 (ja) | 2012-06-28 |
| AU2011345969A1 (en) | 2013-07-11 |
| CA2822787C (en) | 2018-07-17 |
| HRP20160465T1 (hr) | 2016-06-03 |
| DK2657227T3 (en) | 2016-08-01 |
| TW201305112A (zh) | 2013-02-01 |
| CN103270024B (zh) | 2015-07-08 |
| EP2657227A1 (en) | 2013-10-30 |
| EP2657227A4 (en) | 2013-11-27 |
| BR112013015604A2 (pt) | 2018-07-24 |
| JPWO2012086727A1 (ja) | 2014-06-05 |
| AU2011345969B2 (en) | 2016-04-21 |
| BR112013015604B1 (pt) | 2021-11-03 |
| HUE029976T2 (en) | 2017-04-28 |
| JP5781093B2 (ja) | 2015-09-16 |
| CN103270024A (zh) | 2013-08-28 |
| EP2657227B1 (en) | 2016-04-27 |
| US8883792B2 (en) | 2014-11-11 |
| KR101911324B1 (ko) | 2018-10-25 |
| EA022646B1 (ru) | 2016-02-29 |
| TWI527799B (zh) | 2016-04-01 |
| EA201390939A1 (ru) | 2013-12-30 |
| US20130274269A1 (en) | 2013-10-17 |
| CA2822787A1 (en) | 2012-06-28 |
| KR20130142163A (ko) | 2013-12-27 |
| PT2657227T (pt) | 2016-08-01 |
| HK1185619A1 (en) | 2014-02-21 |
| NZ612336A (en) | 2014-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3607A (en) | Substituted imidazopyridazines | |
| SMT201700319T1 (it) | Pirrolidin-2-carbossammidi sostituite | |
| GB201005589D0 (en) | Novel compounds | |
| PL2444395T3 (pl) | Podstawiona pochodna izochinoliny | |
| ZA201300032B (en) | Tetrahydrocarboline derivative | |
| GB201112400D0 (en) | No details | |
| PT2657227T (pt) | Novo derivado de isoquinolina substituída | |
| ZA201304430B (en) | Substituted sodium-1h-pyrazole-5-olate | |
| ZA201303887B (en) | 2-carboxamide-4-piperazinyl-benzofuran derivative | |
| IL216062A0 (en) | Novel isoquinoline derivatives | |
| PL2628733T3 (pl) | Pochodna acylobenzenu | |
| GB201007789D0 (en) | Novel Compound | |
| ZA201300155B (en) | Substituted pyridine compound | |
| PL2671869T3 (pl) | Pochodna tetrahydroizochinoliny | |
| GB201003745D0 (en) | Novel compounds ll | |
| GB201002829D0 (en) | Novel copmounds | |
| GB201002810D0 (en) | Novel compound | |
| GB201002818D0 (en) | Novel compounds | |
| GB201002821D0 (en) | Novel compounds | |
| GB201002799D0 (en) | Novel compounds | |
| GB201002827D0 (en) | Novel compounds | |
| GB201002112D0 (en) | Novel compounds | |
| GB201002097D0 (en) | Novel compounds | |
| GB201002828D0 (en) | Novel compounds | |
| GB201000685D0 (en) | Novel compounds |